Eledon Pharmaceuticals Azioni (NASDAQ: ELDN)

Ultime notizie per Eledon Pharmaceuticals (NASDAQ:ELDN) Azioni

Eledon Pharma

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Eledon Pharmaceuticals, Inc. - Common Stock

Eledon Pharmaceuticals Inc

Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) has outperformed the market over the past 5 years by 3.58% on an annualized basis producing an average annual return of 16.25%. Currently, Carvana has a market capitalization of $26.28 billion. 
Buying $1000 In CVNA: If an investor had bought $1000 of CVNA stock 5 years ago, it would be worth $2,230.16 today based on a price of $195.60 for CVNA at the time of writing.
<h3>Carvana's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745278219_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

CVNA

Here's How Much You Would Have Made Owning Carvana Stock In The Last 5 Years

Though UnitedHealth Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) reported disappointing first-quarter results last week, two analysts from KeyBanc Capital Markets and Truist Securities remain <a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44902410/unitedhealth-group-stock-is-getting-crushed-whats-fueling-the-selloff">bullish on the stock. </a>
Expert Ideas: Both David MacDonald at Truist and Matthew Gillmor at KeyBanc said that although the health care giant's most recent quarter and 2025 earnings guidance missed the mark, they remain bullish on UnitedHealth for the long term. 
Read Next:<a href="https://www.benzinga.com/general/health-care/25/04/44869920/unitedhealth-ceo-says-high-cost-of-us-health-care-simply-not-sustainable"> UnitedHealth CEO Says High Cost Of US Health Care &#8216;Simply Not Sustainable&#8217;&nbsp;</a>
Both analysts said that while the Medicare Advantage utilization trend was troubling, its emergence early in the year will allow time for management to correct course.&nbsp; When coupled with the better-than-expected rate updates for 2026, the analysts see the company recovering into 2026.&nbsp;
The Truist analyst highlighted the narrowing Medicaid rate mismatch and upbeat selling season commentary from management.
KeyBanc sees a "silver lining" in UnitedHealth's ability to correct the RAF coding issues for 2026 and expects the company to factor the higher utilization rates into June bids. The analyst also said competitors like Humana and CVS are "not well positioned to take advantage of UNH's stumble."&nbsp;
The Takeaway: The analysts see UnitedHealth's issues as mostly isolated and "fixable" and maintained bullish ratings on the stock while slashing price targets.&nbsp;
KeyBanc maintained an Overweight rating on UnitedHealth shares, but lowered its price target from $650 to $575. Truist Securities maintained its Buy rating and lowered the price target for UnitedHealth stock from $660 to $580. 
UNH Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro,</a> UnitedHealth shares ended Monday's session 6.35% lower at $425.33. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/04/44903087/amazon-stock-downgraded-price-target-slashed-as-tariffs-create-uncertainty">Amazon Stock Downgraded, Price Target Slashed As Tariffs Create Uncertainty&nbsp;</a></li>
</ul>

Earnings

Health Care

Price Target

Analyst Ratings

General

UnitedHealth Q1 Disappoints, But These Analysts Remain Bullish On The Stock

Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) has outperformed the market over the past 15 years by 7.75% on an annualized basis producing an average annual return of 18.03%. Currently, Lululemon Athletica has a market capitalization of $30.67 billion. 
Buying $100 In LULU: If an investor had bought $100 of LULU stock 15 years ago, it would be worth $1,180.43 today based on a price of $254.24 for LULU at the time of writing.
<h3>Lululemon Athletica's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745277310_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LULU

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

Three major U.S. defense contractors — RTX Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>), Northrop Grumman Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) and Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) — are all scheduled to report earnings before the market opens on Tuesday. Here's a look at what to <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44810625/top-analyst-sees-unprecedented-traction-for-pltr-stock-after-nato-agreement-another-validation-sign">watch in the reports. </a>
What To Know: The Trump administration has signaled potentially historic defense spending, with reports suggesting a Pentagon budget near $1 trillion, which could benefit all three contractors. However, President Donald Trump has sent mixed messages by advocating for increased allied purchases of U.S. weapons while discussing the possibility of cutting U.S. military spending. 
The administration's push for efficiency, led by Elon Musk at the Department of Government Efficiency, introduces more uncertainty for defense contractors, as many major programs are under review. 
Read Next: <a href="https://www.benzinga.com/25/04/44903087/amazon-stock-downgraded-price-target-slashed-as-tariffs-create-uncertainty">Amazon Stock Downgraded, Price Target Slashed As Tariffs Create Uncertainty&nbsp;</a>
RTX: Investors will be looking for continued growth in RTX's Collins Aerospace and Pratt &amp; Whitney units, which both recently announced a slew of <a href="https://www.benzinga.com/news/contracts/25/04/44686376/rtx-pops-as-pratt-whitney-expands-gtf-capacity-collins-aerospace-enhances-offerings">new deals </a>and led 2024's gains.
The company's backlog will also be monitored for continued growth after reaching a record $218 billion at the end of 2024.&nbsp;
According to estimates from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, analysts expect the company to report earnings of $1.35 per share and revenue of $19.79 billion for the quarter.&nbsp;
NOC: Investors will be watching the performance of Northrop&#8217;s four main business segments: Aeronautics Systems, Defense Systems, Mission Systems and Space Systems, as well as updates on 2025 revenue and free cash flow guidance. 
Current expectations are for revenue between $42 billion and $42.5 billion and free cash flow of between $2.9 billion and $3.3 billion.&nbsp;
Earlier in April, Goldman Sachs analyst Noah Poponak upgraded Northrop Grumman stock from Sell to Neutral and raised the price target from $424 to $521. Analysts expect the company to report earnings of $6.26 per share on revenue of $9.94 billion, according to estimates from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>. 
LMT: Last week, Evan Scott <a href="https://www.benzinga.com/25/04/44867490/evan-scott-takes-over-as-lockheed-martin-cfo-succeeding-jesus-jay-malave">was named </a>as Lockheed Martin's CFO, succeeding Jesus Malave, effective immediately. In a press release, the company said it will be reaffirming its previously issued 2025 guidance and will provide updates on other key topics and answer questions with its first quarter earnings release. 
Investors will be watching the company's Aeronautics segment, driven by the F-35 program, which is expected to post solid sales. Analysts expect Lockheed Martin to report earnings of $6.34 per share on revenue of $17.8 billion for the first quarter. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/global/25/04/44899617/90-chance-of-recession-due-to-trumps-tariffs-sharp-slowdown-is-coming-economist-says">90% Chance Of Recession Due To Trump&#8217;s Tariffs: &#8216;Sharp Slowdown&#8217; Is Coming, Economist Says</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/MCMEDIASTUDIOPRO">MC MEDIASTUDIO</a> via Shutterstock

Government

Previews

RTX, Lockheed Martin, Northrup Grumman Report Earnings Tuesday: What To Watch

Some startups break the internet. Others go old school—and still make a fortune.
Ari Siegel, the founder of History By Mail, has proven that even in the age of TikTok and <a href="https://www.benzinga.com/news/25/03/44375147/smart-puppies-are-smarter-than-ai-mark-cubans-surprising-take-on-the-future-of-artificial-intelligence">AI</a>, people still crave the tangible. His company ships replicas of historical documents—complete with authentic-looking paper and calligraphy—straight to subscribers&#8217; mailboxes each month.&nbsp;
<a href="https://www.nbcphiladelphia.com/news/business/money-report/38-year-old-brings-1-million-a-year-snail-mail-company-to-shark-tank-mark-cuban-you-dont-really-need-our-help/4155285/?os=wtmb5utKCxk5refapp6koVwAmR&amp;ref=app#:~:text=History%20By%20Mail%20brought%20in,as%20a%20U.S.%20Senate%20intern.">NBC10 Philadelphia</a> reported that the five-year-old business pulled in more than $1 million in revenue in 2024, and after a recent "Shark Tank" appearance, it had its biggest sales week ever.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>Invest in the future of digital engagement: <a href="https://www.benzinga.com/money/vatom-adv">Own a piece of the $100 billion Metaverse for just $500</a>.</li>
</ul>
<h2 class="wp-block-heading">From Senate Intern to History Entrepreneur</h2>
The idea was born when Siegel interned for the U.S. Senate and visited the Library of Congress. There, he spotted a letter penned by Abraham Lincoln and got inspired to replicate historical artifacts for friends and family. The emotional response he received sparked a business.
He launched History By Mail in January 2019. Early subscribers received documents every two weeks, each tied to major events or iconic figures in American history. But that fast pace quickly became a problem.
"People told us they loved the content, but couldn't keep up," Siegel told <a href="https://www.cnbc.com/2025/04/08/mark-cuban-shark-tank-company-history-by-mail-doesnt-need-help.html">CNBC "Make It."</a> It takes time to really dig into each letter. Everyone's busy." So, the company pivoted to monthly shipments—one letter, one context page, one manageable dose of history.
Trending: <a href="https://www.benzinga.com/money/investing-in-the-midwest-why-multifamily-real-estate-is-a-winning-strategy">This investment company boasts a 33.85% internal rate of return (IRR) for its realized projects, allowing accredited investors to earn passive returns and avoid the headaches of being a landlord.</a>
The simplicity worked. Siegel shared on "Shark Tank" that the company hit $1 million in revenue last year, without outside investment—until now. On the April 4 <a href="https://abc.com/episode/2e5d5998-9d1b-40ca-9f19-c8f12802544e/playlist/PL554912060">episode</a> of "Shark Tank," Siegel pitched the company and asked for $250,000 in exchange for 10% equity. His goal: scale the business through better social media marketing.
<a href="https://www.benzinga.com/startups/25/01/43084861/mark-cubans-29-million-shark-tank-portfolio-from-200k-in-dude-wipes-to-200m-for-beatbox-beverages-im-killing-it">Mark Cuban</a> praised the concept, telling Siegel, "You get to do what you love, and you're making a killing." Cuban and Lori Greiner passed on investing. Kevin O'Leary and Daniel Lubetzky each offered $250,000 for 20%, while Barbara Corcoran later jumped in to team up with Lubetzky. Together, they offered $125,000 each for a combined 20% stake.
Siegel accepted the offer from Lubetzky on air. However, a History By Mail spokesperson later confirmed to CNBC that only Lubetzky's firm, Camino Partners, finalized the deal. Corcoran was not part of the deal.
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
According to CNBC, the "Shark Tank effect" was almost instantaneous. Sales hit a record high within an hour of the episode airing, the company confirmed. While no specific revenue numbers were shared, Siegel said it was the company's strongest sales week to date.
"We want to make historical documents more accessible," Siegel said. "They already belong to the public—they're just not in their hands."
Read Next:
<ul>
<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>
Image: Shutterstock

Mark Cuban Said 'You're Making A Killing'—Then This Founder's History Startup Made $1 Million And Had Its Best Week Ever

ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) has outperformed the market over the past 10 years by 2.34% on an annualized basis producing an average annual return of 11.63%. Currently, ON Semiconductor has a market capitalization of $14.64 billion. 
Buying $1000 In ON: If an investor had bought $1000 of ON stock 10 years ago, it would be worth $2,997.41 today based on a price of $34.73 for ON at the time of writing.
<h3>ON Semiconductor's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745276415_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

Pope Francis has <a href="https://www.benzinga.com/news/25/04/44892537/pope-francis-first-south-american-pontiff-and-peoples-pope-dies-at-88">died at the age of 88</a> leaving a vacancy for the position of the global head of the Catholic Church.
Here's a look at the betting odds for the next pope and why sports bettors believe one Major League Baseball player will hit a home run Monday.
Next Pope Odds: Pope Francis was the first South American pope and was known to many as the "People's Pope" thanks to his advocacy for the poor.
Francis had been pope since 2013 when Pope Benedict XVI resigned.
With the death of Pope Francis, the Conclave, a process to select the next pope, will now take place. Conclave typically happens between 15 and 20 days following the death of the pope, which includes a week of mourning.
Unlike presidents and world leaders, the new pope will not be selected by the public, but instead by a group of cardinals who are under the age of 80. The next pope will likely be a cardinal given past history, but all baptized Catholic males are eligible to become a pope.
Betting on the next pope is currently not allowed in the U.S., but prediction markets and European sportsbooks have odds listed after Monday's news of the pope's passing.
Here are the current betting odds for the next pope from prediction market <a href="https://polymarket.com/markets?_q=pope">Polymarket</a>:
<ul>
<li>Pietro Parolin (Italy): 36%</li>
<li>Luis Antonio Tagle (Philippines): 26%</li>
<li>Peter Erdo (Hungary): 8%</li>
<li>Peter Turkson (Ghana): 7%</li>
<li>Robert Sarah (Guinea): 5%</li>
<li>Matteo Zuppi (Italy): 5%</li>
<li>Raymond Burke (U.S.): 4%</li>
<li>Pierbattista Pizzaballa (Italy): 3%</li>
</ul>
Polymarket also has odds for the continent the winner will be selected from with the current odds:
<ul>
<li>Europe: 62%</li>
<li>Asia: 22%</li>
<li>Africa: 10%</li>
<li>North America: 3%</li>
<li>South America: 1%</li>
<li>Oceania: 1%</li>
</ul>
The prediction market also has odds for when the next pope will be announced, with only a 1% chance that the announcement comes by the end of April. The odds of a new pope announcement by May 9 sit at 59%, with the odds of a new pope revealed by May 31 at 97%.
Dating back to 1963, here are the number of days it took for the next pope to be announced:
<ul>
<li>2013: 13 days</li>
<li>2005: 17 days</li>
<li>1978: 18 days</li>
<li>1978: 20 days</li>
<li>1963: 18 days</li>
</ul>
Polymarket allows users to deposit funds using USDC (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>) via the Polygon (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/matic/usd">MATIC</a>) network or directly from a crypto account with Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>). Winning wagers cash out at $1 per contract. Many of the pope markets have a deadline of Dec. 31, 2025, to cash out or they will turn to $0.
At <a href="https://www.oddschecker.com/us/insight/specials/politics/20250413-next-pope-odds-who-will-take-over-in-vatican-after-passing-of-pope-francis">Oddschecker</a>, the current favorites to be the next pope are:
<ul>
<li>Parolin +350, 22% chance</li>
<li>Tagle: +500, 17% chance</li>
<li>Angelo Scola (Italy): +700, 13% chance</li>
<li>Marc Ouellet (Canada): +700, 13% chance</li>
</ul>
Both Polymarket and Oddschecker show Parolin and Tagle as the favorites, while it could be anyone's guess beyond the two frontrunners before the Conclave begins. Tagle could become the first Filipino pope in history and the first pope from Asia in over 1,000 years.
Parolin has been Francis' secretary of state since 2014 and would likely continue his predecessor's style of leading while also bringing an Italian back to the leadership role after three straight non-Italian popes.. At the age of 67, Tagle could be considered young for a pope and could serve in the leadership role for decades.
Read Also: <a href="https://www.benzinga.com/news/24/09/40864360/pope-francis-criticizes-both-trump-and-kamala-harris-for-supporting-abortion-urges-catholics-to-vote">Pope Francis Criticizes Both Trump And Kamala Harris For Supporting Abortion, Urges Catholics To Vote For &#8216;Lesser Evil&#8217;</a>
MLB Pope Death Connection: Bettors on MLB games and player props are paying close attention to Nick Castellanos and the Philadelphia Phillies who battle the New York Mets Monday night at 7:10 p.m. ET.
Those familiar with baseball know that Castellanos has a knack for hitting home runs on days that have major global events or while the announcers are discussing controversial topics.
Castellanos began the day at odds of +750 to hit a home run at DraftKings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) and the odds have since fallen to +360 with a large number of bets being placed on the MLB hitter.
At BetMGM, Castellanos is the most bet player to hit a home run by more than 3x, <a href="https://x.com/johnewing/status/1914311584815485184">according </a>to John Ewing.
At ESPN Bet, Castellanos home run is the most bet player prop across MLB, NBA and NHL <a href="https://x.com/ButlerBets/status/1914390554948890805">combined</a>, which includes multiple Monday playoff contests.
Here is a list of <a href="https://www.inquirer.com/phillies/nick-castellanos-home-run-meme-biden-trump-20240722.html">examples </a>of when Castellanos has hit home runs:
<ul>
<li>The day Osama Bin Laden was killed</li>
<li>Right before Joe Biden dropped out of the 2024 presidential election</li>
<li>While a broadcaster was apologizing for using a homophobic slur</li>
<li>20th anniversary of the September 11 terrorist attacks (Sept. 11, 2021)</li>
<li>During a broadcaster's tribute to those who made "the ultimate sacrifice" on Memorial Day</li>
<li>Day of the assassination attempt on Donald Trump</li>
</ul>
As the Philadelphia Inquirer points out, Castellanos was on the injured list after Queen Elizabeth II died, so he was unable to keep his tradition of hitting home runs during global events in place. Time will tell if the pope's death is followed by a home run by Castellanos or if sportsbooks clean up from the large number of bets placed on the player prop.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44861571/donald-trump-blasts-too-late-and-wrong-fed-chair-powell-but-polymarket-traders-doubt-his-termination-will-come-fast-enough">Donald Trump Blasts &#8216;Too Late And Wrong&#8217; Fed Chair Powell, But Polymarket Traders Doubt His &#8216;Termination&#8217; Will Come &#8216;Fast Enough&#8217;</a></li>
</ul>
Photo: Shutterstock

Entertainment

Sports Betting

Sports

$ETH

$MATIC

$USDC

DKNG

USDC

Betting Odds For Pope Francis Replacement Show Two Favorites, Plus This Global Event Has MLB Bettors Backing Nick Castellanos To Hit Home Runs

Pan American Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAAS#NYSE">PAAS</a>) has outperformed the market over the past 10 years by 1.48% on an annualized basis producing an average annual return of 10.77%. Currently, Pan American Silver has a market capitalization of $9.77 billion. 
Buying $100 In PAAS: If an investor had bought $100 of PAAS stock 10 years ago, it would be worth $283.89 today based on a price of $26.97 for PAAS at the time of writing.
<h3>Pan American Silver's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745275512_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PAAS

If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today

<a href="https://www.benzinga.com/personal-finance/25/04/44723566/charlie-munger-gave-his-no-1-tip-for-a-long-and-happy-life-avoid-crazy-at-all-costs-but-watch-out-crazy-is-way-more-common-than-you-think">Charlie Munger</a> wasn't just Warren Buffett's right-hand man—he was a billionaire in his own right, a master of patience, and a straight shooter when it came to wealth-building.&nbsp;
For decades, Munger dished out life lessons and money advice like a guy who knew the cheat codes. And he did. When you work shoulder to shoulder with the greatest investor of all time, people tend to lean in when you talk.
One of his final gems came on the <a href="https://www.acquired.fm/episodes/charlie-munger">"Acquired" podcast</a> in October 2023. Munger, sharp as ever in his final months, made it sound almost simple:
"The beauty of it is: <a href="https://www.benzinga.com/personal-finance/24/07/39842841/charlie-munger-said-getting-rich-is-harder-than-ever-but-heres-the-beauty-of-it-you-only-have-to">you only have to get rich once</a>."
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
He wasn't talking about luck. He wasn't pitching get-rich-quick nonsense. He was saying: do the work, build the foundation, and once you're there—you can stop grinding and let the compounding do the heavy lifting.
Munger also made it painfully clear that the beginning is the toughest part. Back in the late ‘90s at a Berkshire Hathaway meeting, he put it bluntly:
"The first $100,000 is a b&#x2A;tch, but you gotta do it. I don't care what you have to do—if it means walking everywhere and not eating anything that wasn't purchased with a coupon, find a way to get your hands on $100,000."
That $100,000 is equivalent to about $200,000 today when adjusted for inflation. So yes, the bar's higher now—but the principle still holds.
Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>
Munger's reasoning? Once you've crossed that first financial threshold, wealth begins to build itself. That initial $100K isn't just a number—it's momentum. It's proof you can delay gratification, make smart choices, and keep money working for you instead of the other way around.
Compound interest becomes your new best friend.
When you invest that first $100,000 wisely, it starts to generate returns. Those returns earn more returns. The snowball effect kicks in, and before you know it, your money's doing more work than you are. But none of that happens if you don't push through that first stretch.
Of course, it's not just about math—it's about mindset.
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
Here are the psychological roadblocks most people hit before even getting started:
Fear of losing money: The stock market can feel like a casino if you don't know what you're doing. But letting inflation quietly eat away at your savings in a checking account? That's a guaranteed loss.
Doubt: If you don't believe wealth is possible for you, you'll never bother trying. Munger's advice wasn't just for the Ivy League elite. It was for anyone willing to hustle and stick with it.
And while Munger didn't <a href="https://www.benzinga.com/personal-finance/25/04/44854326/warren-buffett-surpasses-bill-gates-with-165-billion-fortune-berkshire-is-a-stable-ship-in-a-sea-of-uncertainty">spell out every step to getting rich</a>, he left behind a trail of practical wisdom: live below your means, invest early, and don't get distracted by noise.
The goal isn't to get rich overnight. It's to get there once—and let that be enough.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/investing-in-the-midwest-why-multifamily-real-estate-is-a-winning-strategy">This investment company boasts a 33.85% internal rate of return (IRR) for its realized projects, allowing accredited investors to earn passive returns and avoid the headaches of being a landlord.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Personal Finance

Charlie Munger Said 'You Only Have To Get Rich Once' — But Warned The First $100K Is a 'B*tch' And The Most Important Step To Building Wealth

Antero Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AR#NYSE">AR</a>) has outperformed the market over the past 5 years by 57.45% on an annualized basis producing an average annual return of 70.12%. Currently, Antero Resources has a market capitalization of $9.98 billion. 
Buying $100 In AR: If an investor had bought $100 of AR stock 5 years ago, it would be worth $1,470.64 today based on a price of $32.06 for AR at the time of writing.
<h3>Antero Resources's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745273712_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Antero Resources 5 Years Ago Would Be Worth This Much Today

SMBC

Southern Missouri Bancorp Reports Preliminary Results For Q3; Expects Q3 EPS $1.39 Vs $1.29

Gartner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Gartner, presenting an average target of $508.0, a high estimate of $605.00, and a low estimate of $401.00. A decline of 8.93% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1745272862_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A clear picture of Gartner's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Manav Patnaik &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $475.00&#x7C;$510.00 &#x7C; 
&#x7C;Jason Haas &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Underweight &#x7C; $401.00&#x7C;$488.00 &#x7C; 
&#x7C;Manav Patnaik &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $510.00&#x7C;$600.00 &#x7C; 
&#x7C;Joshua Chan &#x7C;UBS &#x7C;Lowers &#x7C;Buy &#x7C; $500.00&#x7C;$565.00 &#x7C; 
&#x7C;Jeffrey Meuler &#x7C;Baird &#x7C;Lowers &#x7C;Outperform &#x7C; $557.00&#x7C;$605.00 &#x7C; 
&#x7C;Jeffrey Meuler &#x7C;Baird &#x7C;Raises &#x7C;Outperform &#x7C; $605.00&#x7C;$579.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Gartner. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Gartner compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Gartner's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Gartner's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/IT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Gartner analyst ratings.</a>
<h2>All You Need to Know About Gartner</h2>
Gartner Inc provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services. The company operates through three business segments, namely Research, Conferences and Consulting. The company generates majority of the revenue from Research segment.
<h3>Understanding the Numbers: Gartner's Finances</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Gartner displayed positive results in 3M. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 8.13%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Gartner's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 23.24%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Gartner's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 32.89%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 4.87%, the company showcases effective utilization of assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.13, caution is advised due to increased financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 6 Analysts Discuss Gartner Stock

Jones Trading analyst Jason Weaver maintains Dynex Cap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DX#NYSE">DX</a>) with a Buy and lowers the price target from $13.25 to $12.5.

Jones Trading Maintains Buy on Dynex Cap, Lowers Price Target to $12.5

In the preceding three months, 12 analysts have released ratings for State Street (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>), presenting a wide array of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">7</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for State Street, presenting an average target of $108.42, a high estimate of $139.00, and a low estimate of $85.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 6.06%. 
<img src="https://www.benzinga.com/files/images/story/2025/1745272854_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive State Street. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;David Konrad &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Outperform &#x7C; $113.00&#x7C;$118.00 &#x7C; 
&#x7C;David Smith &#x7C;Truist Securities &#x7C;Lowers &#x7C;Hold &#x7C; $85.00&#x7C;$89.00 &#x7C; 
&#x7C;Jason Goldberg &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $120.00&#x7C;$127.00 &#x7C; 
&#x7C;Betsy Graseck &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Overweight &#x7C; $102.00&#x7C;$132.00 &#x7C; 
&#x7C;David Smith &#x7C;Truist Securities &#x7C;Lowers &#x7C;Hold &#x7C; $89.00&#x7C;$104.00 &#x7C; 
&#x7C;Connor Lynagh &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Overweight &#x7C; $132.00&#x7C;$139.00 &#x7C; 
&#x7C;Ebrahim Poonawala &#x7C;B of A Securities &#x7C;Raises &#x7C;Underperform &#x7C; $99.00&#x7C;$98.00 &#x7C; 
&#x7C;Glenn Schorr &#x7C;Evercore ISI Group &#x7C;Lowers &#x7C;Outperform &#x7C; $106.00&#x7C;$109.00 &#x7C; 
&#x7C;Mike Mayo &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $113.00&#x7C;$118.00 &#x7C; 
&#x7C;Keith Horowitz &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $100.00&#x7C;$105.00 &#x7C; 
&#x7C;Connor Lynagh &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Overweight &#x7C; $139.00&#x7C;$142.00 &#x7C; 
&#x7C;Brian Bedell &#x7C;Deutsche Bank &#x7C;Lowers &#x7C;Hold &#x7C; $103.00&#x7C;$104.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to State Street. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of State Street compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of State Street's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/STT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on State Street analyst ratings.</a>
<h2>Get to Know State Street Better</h2>
State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $47 trillion in assets under custody and administration and $4.7 trillion assets under management as of Dec. 31, 2024, State Street operates globally in more than 100 geographic markets and employs about 53,000 worldwide.
<h3>Financial Milestones: State Street's Journey</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Negative Revenue Trend: Examining State Street's financials over 3M reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -3.75% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: State Street's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 18.18%, the company may face hurdles in effective cost management.
Return on Equity (ROE): State Street's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.62%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): State Street's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.16%, the company may face hurdles in achieving optimal financial performance.
Debt Management: State Street's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.59, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>What Are Analyst Ratings?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 12 Analysts Discuss State Street Stock

In the latest quarter, 10 analysts provided ratings for CarMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated CarMax and provided 12-month price targets. The average target is $90.3, accompanied by a high estimate of $105.00 and a low estimate of $65.00. A 5.54% drop is evident in the current average compared to the previous average price target of $95.60. 
<img src="https://www.benzinga.com/files/images/story/2025/1745272845_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive CarMax. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Seth Basham &#x7C;Wedbush &#x7C;Maintains &#x7C;Outperform &#x7C; $90.00&#x7C;$90.00 &#x7C; 
&#x7C;Seth Basham &#x7C;Wedbush &#x7C;Maintains &#x7C;Outperform &#x7C; $90.00&#x7C;$90.00 &#x7C; 
&#x7C;Steven Shemesh &#x7C;RBC Capital &#x7C;Lowers &#x7C;Outperform &#x7C; $80.00&#x7C;$103.00 &#x7C; 
&#x7C;Seth Basham &#x7C;Wedbush &#x7C;Lowers &#x7C;Outperform &#x7C; $90.00&#x7C;$100.00 &#x7C; 
&#x7C;Craig Kennison &#x7C;Baird &#x7C;Lowers &#x7C;Outperform &#x7C; $90.00&#x7C;$95.00 &#x7C; 
&#x7C;Chris Pierce &#x7C;Needham &#x7C;Lowers &#x7C;Buy &#x7C; $92.00&#x7C;$101.00 &#x7C; 
&#x7C;Seth Basham &#x7C;Wedbush &#x7C;Maintains &#x7C;Outperform &#x7C; $100.00&#x7C;$100.00 &#x7C; 
&#x7C;Rajat Gupta &#x7C;JP Morgan &#x7C;Lowers &#x7C;Underweight &#x7C; $65.00&#x7C;$72.00 &#x7C; 
&#x7C;Michael Montani &#x7C;Evercore ISI Group &#x7C;Lowers &#x7C;Outperform &#x7C; $105.00&#x7C;$107.00 &#x7C; 
&#x7C;Chris Pierce &#x7C;Needham &#x7C;Raises &#x7C;Buy &#x7C; $101.00&#x7C;$98.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CarMax. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of CarMax compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of CarMax's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into CarMax's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/KMX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on CarMax analyst ratings.</a>
<h2>Delving into CarMax's Background</h2>
CarMax sells, finances, and services used and new cars through a chain of around 250 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales were 83% of fiscal 2025 revenue and wholesale about 17%, with the remaining portion composed of extended service plans and repair. In fiscal 2025, the company retailed and wholesaled 789,050 and 544,312 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the US but still estimates that it had only about 3.7% US market share of vehicles 0-10 years old in calendar 2024. It seeks over 5% share. CarMax is based in Richmond, Virginia.
<h3>Key Indicators: CarMax's Financial Health</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Positive Revenue Trend: Examining CarMax's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 6.69% as of 28 February, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: CarMax's net margin is impressive, surpassing industry averages. With a net margin of 1.5%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): CarMax's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.44% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): CarMax's ROA stands out, surpassing industry averages. With an impressive ROA of 0.33%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: CarMax's debt-to-equity ratio is below the industry average at 3.08, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: CarMax Through The Eyes Of 10 Analysts

6 analysts have expressed a variety of opinions on Rexford Industrial Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REXR#NYSE">REXR</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $42.5, with a high estimate of $47.00 and a low estimate of $38.00. Highlighting a 6.24% decrease, the current average has fallen from the previous average price target of $45.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1745272838_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Rexford Industrial Realty. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Samir Khanal &#x7C;Evercore ISI Group &#x7C;Lowers &#x7C;Outperform &#x7C; $40.00&#x7C;$43.00 &#x7C; 
&#x7C;Greg McGinniss &#x7C;Scotiabank &#x7C;Lowers &#x7C;Sector Perform &#x7C; $39.00&#x7C;$47.00 &#x7C; 
&#x7C;Brendan Lynch &#x7C;Barclays &#x7C;Lowers &#x7C;Underweight &#x7C; $38.00&#x7C;$41.00 &#x7C; 
&#x7C;David Rodgers &#x7C;Baird &#x7C;Lowers &#x7C;Neutral &#x7C; $47.00&#x7C;$48.00 &#x7C; 
&#x7C;Greg McGinniss &#x7C;Scotiabank &#x7C;Lowers &#x7C;Sector Perform &#x7C; $47.00&#x7C;$48.00 &#x7C; 
&#x7C;Michael Mueller &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $44.00&#x7C;$45.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Rexford Industrial Realty. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Rexford Industrial Realty compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Rexford Industrial Realty's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Rexford Industrial Realty's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/REXR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Rexford Industrial Realty analyst ratings.</a>
<h2>Discovering Rexford Industrial Realty: A Closer Look</h2>
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.
<h3>Financial Insights: Rexford Industrial Realty</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Rexford Industrial Realty's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 3.87%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Rexford Industrial Realty's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 27.09%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Rexford Industrial Realty's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 0.81%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.53%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.39, Rexford Industrial Realty adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

REXR

What 6 Analyst Ratings Have To Say About Rexford Industrial Realty

Across the recent three months, 5 analysts have shared their insights on New Oriental Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $48.8, along with a high estimate of $52.00 and a low estimate of $44.00. This current average represents a 35.79% decrease from the previous average price target of $76.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1745272831_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of New Oriental Education among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;DS Kim &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $48.00&#x7C;$50.00 &#x7C; 
&#x7C;Michelle Fang &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $50.00&#x7C;$83.00 &#x7C; 
&#x7C;Eddy Wang &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $52.00&#x7C;$83.00 &#x7C; 
&#x7C;Linda Huang &#x7C;Macquarie &#x7C;Lowers &#x7C;Underperform &#x7C; $44.00&#x7C;$79.00 &#x7C; 
&#x7C;DS Kim &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $50.00&#x7C;$85.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to New Oriental Education. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of New Oriental Education compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of New Oriental Education's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of New Oriental Education's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/EDU/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on New Oriental Education analyst ratings.</a>
<h2>Discovering New Oriental Education: A Closer Look</h2>
New Oriental is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation, consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in the livestreaming e-commerce market.
<h3>New Oriental Education: Financial Performance Dissected</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: New Oriental Education's remarkable performance in 3M is evident. As of 30 November, 2024, the company achieved an impressive revenue growth rate of 19.44%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: New Oriental Education's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 3.07%, the company may face hurdles in effective cost management.
Return on Equity (ROE): New Oriental Education's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 0.83%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): New Oriental Education's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.42%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: New Oriental Education's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.2.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

New Oriental Education & Technology Group

What 5 Analyst Ratings Have To Say About New Oriental Education

In the current session, Donaldson Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCI#NYSE">DCI</a>) is trading at $61.70, after a 1.66% decrease. Over the past month, the stock decreased by 9.65%, and in the past year, by 14.83%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1745272822_0.png" alt="Past Year Chart" />

<h3>Comparing Donaldson P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 25.15 in the Machinery industry, Donaldson Inc. has a lower P/E ratio of 18.35. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1745272822_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: Donaldson

In the latest quarter, 6 analysts provided ratings for LKQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKQ#NASDAQ">LKQ</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $56.17, along with a high estimate of $60.00 and a low estimate of $48.00. Highlighting a 0.28% decrease, the current average has fallen from the previous average price target of $56.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1745272820_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive LKQ. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Gary Prestopino &#x7C;Barrington Research &#x7C;Maintains &#x7C;Outperform &#x7C; $60.00&#x7C;$60.00 &#x7C; 
&#x7C;Gary Prestopino &#x7C;Barrington Research &#x7C;Maintains &#x7C;Outperform &#x7C; $60.00&#x7C;$60.00 &#x7C; 
&#x7C;Samik Chatterjee &#x7C;JP Morgan &#x7C;Raises &#x7C;Overweight &#x7C; $49.00&#x7C;$48.00 &#x7C; 
&#x7C;Gary Prestopino &#x7C;Barrington Research &#x7C;Maintains &#x7C;Outperform &#x7C; $60.00&#x7C;$60.00 &#x7C; 
&#x7C;Gary Prestopino &#x7C;Barrington Research &#x7C;Maintains &#x7C;Outperform &#x7C; $60.00&#x7C;$60.00 &#x7C; 
&#x7C;Samik Chatterjee &#x7C;JP Morgan &#x7C;Lowers &#x7C;Overweight &#x7C; $48.00&#x7C;$50.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to LKQ. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of LKQ compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of LKQ's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/LKQ/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on LKQ analyst ratings.</a>
<h2>Delving into LKQ's Background</h2>
Since forming in 1998 to consolidate the auto salvage business in the United States, LKQ has developed into a leading distributor of aftermarket and recycled auto parts with around 1,500 facilities across North America and Europe. The company primarily sells into the professional channel and offers an assortment of collision and mechanical parts to both body shops and mechanical repair shops. It also continues to operate more than 70 LKQ pick-your-part junkyards. Separate from the self-service business, LKQ typically purchases around 250,000 salvage vehicles annually that are used to extract vehicle parts for resale.
<h3>Unraveling the Financial Story of LKQ</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Negative Revenue Trend: Examining LKQ's financials over 3M reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately -4.11% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 4.65%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): LKQ's ROE stands out, surpassing industry averages. With an impressive ROE of 2.55%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.03%, the company showcases effective utilization of assets.
Debt Management: LKQ's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.93.
<h2>What Are Analyst Ratings?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On LKQ Through 6 Analysts

Carpenter Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>) has outperformed the market over the past 20 years by 1.79% on an annualized basis producing an average annual return of 9.6%. Currently, Carpenter Tech has a market capitalization of $8.37 billion. 
Buying $100 In CRS: If an investor had bought $100 of CRS stock 20 years ago, it would be worth $601.04 today based on a price of $167.60 for CRS at the time of writing.
<h3>Carpenter Tech's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745272817_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Carpenter Tech 20 Years Ago Would Be Worth Today

Press Releases

Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference

Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook

Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference

Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results

ELDN

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Anika Therapeutics

Annexon

Cardiff Oncology

Design Therapeutics

Eledon Pharmaceuticals

Gossamer Bio

TuHURA Biosciences

Inhibrx Biosciences

INmune Bio

Innate Pharma S.A. - American Depositary Shares

Innate Pharma

Inventiva S.A. - American Depository Shares

Inventiva

Lexicon Pharmaceuticals, Inc. - Common Stock

Lexicon Pharmaceuticals

Nanobiotix

Neurogene

Nuvectis Pharma

Ocugen

Protalix BioTherapeutics, Inc. (DE) Common Stock

Protalix BioTherapeutics

Prime Medicine

Rezolute

Sangamo Therapeutics, Inc. - Common Stock

Sangamo Therapeutics

Solid Biosciences

TriSalus Life Sciences, Inc. - Common Stock

TriSalus Life Sciences

Tevogen Bio Holdings

Voyager Therapeutics, Inc. - Common Stock

Comments

Eledon Pharmaceuticals

Notizie

Ultime notizie per Eledon Pharmaceuticals (NASDAQ:ELDN) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO